Search Results 571-580 of 16586 for Valproate

  1. Clinical trials - Gastroenterology and Hepatology

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  2. Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer - Mayo Clinic

    About this study. The study seeks to assess the efficacy of veliparib (ABT-888) in combination with carboplatin and etoposide in participants with extensive ...

  3. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Clinical Trials · A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With ...

  4. Progel Vascular Sealant - Clinical Trials

    This study is being conducted to evaluate the safety and effectiveness of the Progel Vascular Sealant for use in vascular reconstructions to achieve adjunctive ...

  5. Diltiazem (intravenous route) - Side effects & uses - Mayo Clinic

    It belongs to a group of drugs called calcium channel blocking agents. Diltiazem affects the movement of calcium into the cells of the heart and blood vessels.

  6. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  7. Publications - Eva Kubrova - Mayo Clinic

    Her F, Kubrova E, ElSaban M, Dombovy-Johnson M, Mostert K, D'Souza R. Complex Regional Pain Syndrome: Updates and Current Evidence Current Physical Medicine and ...

  8. Immune-mediated adverse events - Mayo Clinic

    CT chest scan, PET-CT scan and transbronchoscopic biopsy indicating immune-mediated adverse events. Share · Tweet . IMG-20400457.

  9. VTP-1000 in celiac disease - Clinical Trials

    The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of VTP-1000 to define a dose and schedule for further ...

  10. Clinical trials - Oncology (Medical)

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...